Infusive US Trust - Infusive Compounding Global Equities ETF EBIT

Infusive US Trust - Infusive Compounding Global Equities ETF (JOYY) currently reports a EBIT of $120M as of June 2026. That compares with $160M in the prior-year period — down 28.2% year over year. That is above the sector sector average of $-9.6M. Use the charts on this page to explore Infusive US Trust - Infusive Compounding Global Equities ETF's EBIT history and peer comparisons.

Infusive US Trust - Infusive Compounding Global Equities ETF's EBIT decreased from $160M to $120M — a 28.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Infusive US Trust - Infusive Compounding Global Equities ETF's EBIT of $120M is higher than the its sector sector average of $-9.6M. That is roughly 1296.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Infusive US Trust - Infusive Compounding Global Equities ETF reported $120M in EBIT as of June 2026. That compares with $160M in the prior-year period — down 28.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-9.6M. From there, open related valuation or income-statement pages for Infusive US Trust - Infusive Compounding Global Equities ETF, and consider following JOYY for alerts when major investors trade the stock.